Trials / Completed
CompletedNCT04378205
Pulpal Blood Flow Changes Using SuperElastic 0.018-inch Nickel Titanium
Pulpal Blood Flow Changes Related to Using SuperElastic 0.018-inch Nickel Titanium as the First Orthodontic Alignment Archwire: A Prospective Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Jordan University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
to record pulpal blood flow (PBF) changes associated with using 0.018-inch Nickel Titanium (NiTi) as the first alignment archwire during fixed orthodontic treatment.
Detailed description
Forty healthy patients with lower arch mild crowding with less than 2mm contact point displacement at any teeth were included. A split mouth study design was applied. Where each patient received 2 archwire sizes at one time joined in the midline by crimpable hook and applied in the lower arch. Patients were assigned into one of 2 groups based on archwire sizes used. Group (1); 0.014-inch and 0.018-inch NiTi and Group (2); 0.016-inch and 0.018-inch NiTi. A Laser Doppler Flowmeter was used to measure PBF at different time intervals (T0-T5).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 0.014-inch NiTi on one side /0.018-inch NiTi on the other side | Where each patient received 2 archwire sizes (0.014-inch and 0.018-inch) at one time joined in the midline by crimpable hook and applied in the lower arch. |
| PROCEDURE | 0.016-inch NiTi on one side /0.018-inch NiTi on the other side | Where each patient received 2 archwire sizes (0.016-inch and 0.018-inch) at one time joined in the midline by crimpable hook and applied in the lower arch. |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2020-05-07
- Last updated
- 2020-05-07
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT04378205. Inclusion in this directory is not an endorsement.